MedPath
HSA Approval

BREXIN TABLET 20 mg

SIN07791P

BREXIN TABLET 20 mg

BREXIN TABLET 20 mg

July 15, 1994

HYPHENS PHARMA PTE. LTD.

HYPHENS PHARMA PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantHYPHENS PHARMA PTE. LTD.
Licence HolderHYPHENS PHARMA PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

M01AC01

piroxicam

Manufacturer Information

HYPHENS PHARMA PTE. LTD.

CHIESI FARMACEUTICI SPA

Active Ingredients

PIROXICAM-BETA-CYCLODEXTRIN EQV PIROXICAM

20 mg

Piroxicam

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.